Phase II study of weekly irinotecan and carboplatin for refractory or relapsed small-cell lung cancer-Reference-Cited by-同舟云学术

Phase II study of weekly irinotecan and carboplatin for refractory or relapsed small-cell lung cancer

Published:2002-09 Issue:3 Volume:37 Page:319-323
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Naka Nobuyuki,Kawahara Masaaki,Okishio Kyoichi,Hosoe Shigeto,Ogawara Mitsumasa,Atagi Shinji,Takemoto Yuuji,Ueno Kiyonobu,Kawaguchi Tomoya,Tsuchiyama Tessei,Furuse Kiyoyuki

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference13 articles.

1. Cancer: small cell lung cancer;Murren,2001

2. Phase II study of paclitaxel, ifosfamide, and cisplatin as second-line treatment in relapsed small-cell lung cancer;Kosmas;J. Clin. Oncol.,2001

3. Predictors of survival following relapse or progression of small cell lung cancer. Southwest Oncology Group Study 8605 report and analysis of recurrent disease data base;Albain;Cancer,1993

4. Combination of irinotecan and etoposide for treatment of refractory or relapsed small-cell lung cancer;Masuda;J. Clin. Oncol.,1998

5. Effects of carboplatin in combination with other anticancer agents on human leukemia cell lines;Kano;Leuk. Res.,1993

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms;Pneumologie;2023-10

2. Treatment strategy for patients with relapsed small-cell lung cancer: past, present and future;Translational Lung Cancer Research;2020-04

3. Cost-effectiveness analysis of sensitive relapsed small-cell lung cancer based on JCOG0605 trial;Clinical and Translational Oncology;2017-11-02

4. Second-line treatments of small-cell lung cancers;Expert Review of Anticancer Therapy;2017-09-08

5. Differenzialtherapie des fortgeschrittenen metastasierten kleinzelligen Lungenkarzinoms;Der Onkologe;2017-04-04